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1. Introduction
  Chikungunya fever is a viral disease caused by an alpha 
virus that is spread by bite of Aedes aegypti (Ae. aegypti) 
mosquito. The name is derived from the “Makonde” word 
meaning “that which bends up” in reference to the stooped 
posture developed as a result of the arthritic symptoms of 
the disease. The disease causes crippling arthralgia and 
frequent arthritis that accompany fever, chills, headache, 
nausea, vomiting, low back pain and rash are clinically 
distinctive[1]. Chikungunya is an emerging vector-borne 
disease and has been reported from countries of South and 
East Africa, South Asia, South-East Asia and, in 2007, 
from Italy. In the South-East Asia region, outbreaks were 
documented from India, Indonesia, Maldives, Myanmar, 
Sri Lanka and Thailand. Although it is not a killer disease, 
high morbidity rates and prolonged polyarthritis lead to 
considerable disability in a proportion of the affected 
population and can cause substantial socioeconomic 
impact in affected countries. Chikungunya is a new, 
emerging disease and it has not received sufficient 
coverage yet in the medical curricula of member states[2]. 
Several indigenous drugs have been described in Siddha 
and Ayurveda for the management of inflammation, 
fever and other diseases. In the long term treatment of 
chronic disorders, like rheumatic diseases, combinations 
of different plants families and species active principles 
often exhibit remarkable potency and tolerance[3]. It is well 
documented that the plant possessing anti-inflammatory 
property also having antipyretic and analgesic activities 
or vice versa. The nilavembu kudineer choornam (NKC) is a 
classical preparation used in the treatment of chikungunya 
fever as Siddha medicine in Tamil Nadu, India. It is a 
combination of commonly used food materials along with 
medicinal plants. NKC composition is equal proportion of 
heartwood of Santalum album Linn. (Santalaceae), rhizomes 
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of Zingiber officinale Rosc. (Zingiberaceae), fruits of Piper 
nigrum Linn (Piperaceae), whole plant of Andrographis 
paniculata (Burm) Wall. ex Nees (Acanthaceae), tubers 
of Cyperus rotundus Linn. (Cyperaceae), roots of Vetiveria 
zizanioides (Linn) Nash. (Poaceae), whole plant of Hedyotis 
corymbosa (Linn.) Lam. (Rubiaceae), root of Plectranthus 
vettiveroides (Linn.) Nash. (Lamiaceae) and whole plant 
of Trichosanthes cucumerina Linn. (Curcurbitaceae). All 
these plants are used traditionally in the treatment of fever, 
inflammation, arthralgia, arthritis, gastric ulcer, jaundice 
and general debility conditions[4-6]. In chikungunya, 
only symptomatically treatment has recommended with 
paracetamol and non-steroidal anti-inflammatory drugs 
(NSAIDs). Till-date, there is no specific treatment and 
vaccine for the prevention of chikungunya fever[2]. NKC is 
prescribed in the government hospitals, Tamil Nadu, India 
at the time of chikungunya fever season. But, up-to-date, 
its efficacy is not scientifically documented and hence, the 
present study was undertaken to investigate anti-pyretic, 
anti-inflammatroy and analgesic potential of EENKC in 
animal models to support its actions. 
2. Materials and methods
2.1. Extraction of NKC
  The NKC was procured from Dr.Anbarasu, MD (Siddha)., 
Government Primary Health Center, Pappanadu, Tanjore, 
Tamil Nadu. The extraction of NKC (240 g) was carried out 
by soxhlet apparatus using 95% of ethanol as a solvent for 
72 h. The extract was concentrated under vacuum using a 
rotary evaporator and dried. The total yield of the extract 
was 29.43 g. The EENKC was stored at 2-8 曟 until the 
completion of pharmacological studies. 
2.2. Animals
  Female Wistar albino rats (150-200 g) were used to assess 
the antipyretic activity.  In the case of anti-inflammatory 
and analgesic activity, Wistar albino rats either sex (150-
200 g) and male Swiss albino mice (25-30 g) were used 
respectively. Female mice (25-30 g) were used to assess the 
acute toxicity. All animals were kept and maintained under 
standard laboratory conditions of temperature (22依2) 曟,
humidity (45依5) 曟 and 12 h light: 12 h dark cycle. The 
animals were fed with normal laboratory diet and allowed 
to drink tap water ad libitum. The studies were carried out 
in accordance with institutional ethical guidelines for the 
care of laboratory animals of KMCH College of Pharmacy, 
Coimbatore, India. The study was initiated after the 
approval of institutional animal ethical committee (KMCRET/
PH/14/2008). 
2.3. Chemicals 
  Carrageenan and brewer’s yeast was procured from 
Himedia laboratories, Mumbai, India. Other solvents 
and drugs used were of analytical grade and obtained 
commercially. 
2.4. Acute toxicity study
  Acute oral toxicity study was performed as per Organization 
for Economic Cooperation and Development guidelines[7]. 
The EENKC was administered to 3 female mice in a single 
dose by gavage using oral needle. If 2 mice died or 2-3 
mice are alive out of 3 mice after 24 h, another 3 mice were 
received EENKC as per guidelines to find the acute toxicity. 
Animals are fasted 3 h prior to dosing (food was withheld for 
3 h but not water). During the period of fasting, mice were 
weighed and EENKC was administered. After the EENKC 
administration, food was withheld 2 h. Animals are observed 
individually after dosing at least once during the first 30 
min, periodically during the first 24 h, with special attention 
given during the first 4 h, and daily thereafter, for a total 
of 14 d. Animals are removed, if any humanely killed for 
animal’s welfare reasons or are found dead. The postmortem 
examination was carried out in dead animals to determine 
cause of death.
2.5. Brewer’s yeast induced pyrexia
  Animals were selected for the experiment after 
confirmation of approximate constant rectal temperature 
for 7 d. The antipyretic activity of the EENKC was evaluated 
based on brewer’s yeast-induced pyrexia in rats. Pyrexia 
was induced by subcutaneous injection of 10 mL/kg of 15% 
w/v brewer’s yeast suspension in 0.09% of saline below 
the nape of the neck[8,9]. The rectal temperature of each rat 
was measured using a digital thermometer (BD™ rapid flex) 
before injection of the yeast. 18 h post challenge, induction 
of fever was confirmed by measuring rectal temperature of 
the rats. 
2.6. Experimental design for antipyretic activity
  The rats showed rectal temperature of at least 38.0 曟 
were selected for to assess the antipyretic activity[9]. Fever 
induced rats were divided in to four groups of six animals 
in each group. Group 1 served as negative control which 
received propylene glycol (10 mL/kg), group 2 served as 
positive control which received paracetamol (150 mg/kg), and 
group 3 and 4 served as extract treatment which received 
EENKC 200 and 400 mg/kg respectively. After dosing the 
respective group, the rectal temperature was recorded 
over a period of 1 to 5 h[8].  Paracetamol and EENKC 
were suspended in propylene glycol before prior to oral 
administration. 
2.7. Carrageenan induced rat paw oedema
  Acute inflammation was produced by subplantar injection 
of 0.1 mL of 1% suspension of carrageenan in normal 
saline, in the right hind paw of the rats, 1 h after the oral 
administration of doses of the EENKC, positive and negative 
control substances to the respective groups[8].
2.8. Experimental design for anti-inflammatory activity
  The rats were divided into four groups of six animals 
in each group. Group 1 served as negative control which 
received propylene glycol (10 mL/kg), group 2 served as 
positive control which received indomethacin (10 mg/kg), 
group 3 and 4 served as extract treatment which received 
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EENKC 200 and 400 mg/kg. The paw volume was measured 
plethysmographically (Inco-Niviqure, Version 60.1, India) at 
0, 1, 3 and 5 h after the carrageenan injection. Indomethacin 
and EENKC was suspended in propylene glycol before oral 
administration[8]. 
2.9. Acetic acid induced writhing test
  Acetic acid 0.6% v/v (10 mL/kg) was injected by 
intraperitoneal route one hour after administration of the 
EENKC, positive and negative control substance to the 
respective groups[10].
2.10. Experimental design for analgesic activity
  Male Swiss mice were divided four groups of six animals 
in each group. Group 1 served as negative control which 
received propylene glycol (10 mL/kg), group 2 served as 
positive control which received aspirin (100 mg/kg), group 3 
and 4 served as extract treatment which received EENKC 200 
and 400 mg/kg. After administration of acetic acid, number 
of writhes (i.e. index of pain reaction against chemical 
stimuli characterized by abdominal muscle contraction 
together with turning of trunk and extension of hind limbs) 
was counted over a period of 20 min[10]. The standard drug 
and EENKC were suspended in propylene glycol prior to 
oral administration. 
2.11. Statistical analysis
  All the data expressed as mean 依 SEM were evaluated 
by one-way analysis of variance (ANOVA), followed by 
Dunnett’s test for multiple comparisons and values of P < 
0.05 were considered as statistically significant.
3. Results   
3.1. Acute toxicity study
  The oral administration of EENKC at the dose 2 000 mg/
kg did not exhibit any signs of toxicity up to 14 d and no 
animals were died. This indicates that EENKC was nontoxic 
in mice up to an oral dose of 2 000 mg/kg of body weight. 
Therefore, the biological evaluation was carried out using 
200 and 400 mg/kg dose levels.
3.2. Antipyretic activity 
  Administration of EENKC 200 mg/kg and paracetamol (150 
mg/kg) was significantly (P<0.01) reduced pyrexia at 1 to 
5 h compared to 0 h of the same group animals. At a dose 
of 400 mg/kg, EENKC did not show significant reduction in 
pyrexia at 1 and 2 h compared 0 h. But, it reduced pyrexia 
significantly (P<0.01) at 3, 4 and 5 h compared to 0 h of 
the same group animals. The EENKC 200 mg/kg has equal 
and consistent efficacy to reduce pyrexia compared to 
paracetamol 150 mg/kg at 1 to 5 h (Table 1).  
3.3. Anti-inflammatory activity
  The efficacy of the EENKC 400 mg/kg was not significant at 
1 h, but it showed significant activity at 3 h (P<0.01) and 5 h 
(P<0.05). The EENKC 200 mg/kg showed more significant 
(P<0.01) anti-inflammatory activity at 1 h compared to 
control group than standard drug indomethacin (10 mg/kg, 
P<0.05). The efficacy of the EENKC 200 mg/kg was more 
consistent and significant (P<0.01) than EENKC 400 mg/kg. 
The higher level of inhibition of inflammation with EENKC 
200 mg/kg revealed the greater efficacy than indomethacin, 
but there is no statistically significant efficacy (Table 2).
3.4. Analgesic activity
  Both the dose (200 and 400 mg/kg) of EENKC and aspirin 
(100 mg/kg) pretreatment animals significantly (P<0.01) 
reduced the painful response produced by acetic acid, 
manifested as writhing compared to the control group 
animals (Table 3).
Table 1
Effect of ethanolic extract of nilavembu kudineer choornam on brewer’s yeast induced pyrexia.
Treatment Dose (mg/kg)
Rectal temperature in 曟 at various times intervals
-18 h 0 h 1 h 2 h 3 h 4 h 5 h
Control Vehicle (5 mL/kg) 37.41 依 0.04 38.48 依 0.04 38.70 依 0.06 38.61 依 0.07 38.71 依 0.04 38.80 依 0.03 38.85 依 0.03
Paracetamol 150 37.13 依 0.05 38.66 依 0.06 37.66 依 0.10* 37.45 依 0.11* 37.30 依 0.04* 37.25 依 0.02* 37.21 依 0.06*
EENKC 200 37.33 依 0.13 38.56 依 0.12 37.68 依 0.10* 37.58 依 0.14* 37.51 依 0.03* 37.43 依 0.09* 37.20 依 0.05*
EENKC 400 37.16 依 0.07 38.21 依 0.16 38.01 依 0.23ns 37.63 依 0.15ns 37.46 依 0.07* 37.26 依 0.11* 37.23 依 0.14*
All data were expressed in mean 依 SEM (n=6). *P<0.01 compared with 0 h of the same group. nsNo significance with 0 h of the same group. 
Table 2
Effect of ethanolic extract of nilavembu kudineer choornam on carrageenan-induced rat paw edema.
Treatment Dose (mg/kg)
Rat paw edema volume at different time interval (mL)
0 h 1 h 3 h 5 h
Control Vehicle (5 mL/kg) 1.438 依 0.03   1.706 依 0.06   1.872 依 0.05   2.011 依 0.02
Indomethacin   10 1.429 依 0.01    1.524 依 0.03*     1.626 依 0.03**     1.665 依 0.07**
EENKC 200 1.416 依 0.04     1.406 依 0.05**     1.487 依 0.04**     1.635 依 0.05**
EENKC 400 1.423 依 0.03     1.630 依 0.04ns     1.562 依 0.07**   1.775 依 0.05*
All data were expressed in mean 依 SEM (n=6). *P<0.05 compared with control group. **P<0.01 compared with control group.  nsNo significance 
compared with control group.
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4. Discussion
  In chikungunya, fever is one of the commonest clinical 
features and it was reported in 92% of the cases and 
varies from low grade to high grade, lasting for 24 to 48 
h. Fever rises abruptly in some, reaching 39 to 40 , with 
shaking chills and rigor and usually subsides with use of 
antipyretics[2]. Fever is caused as a secondary impact of 
infection, malignancy or other diseased states. It is the 
body’s natural defence to create an environment where 
infectious agent or damaged tissue cannot survive. It leads 
to enhanced formation of pro-inflammatory mediator’s 
(cytokines like interleukin 1毬, 毩, 毬, and tumor necrosis 
factor-alpha (TNF-毩)), which increase the synthesis of 
prostaglandin E2 (PGE2) near peptic hypothalamus area, 
triggering the hypothalamus to elevate the body temperature. 
The inhibition of cyclooxygenase-2 (COX-2) expression 
leads to reduction in the elevated body temperature by 
inhibits PGE2 synthesis has reported as common mode of 
action to antipyretic agents[11]. The significant reduction of 
fever by EENKC on the brewer’s yeast induced pyrexia in rat 
supporting the antipyretic potentials of NKC in chikungunya 
fever. This property may be due to inhibiting the  enzyme 
cyclooxygenase  and  reducing  the  level  of PGE2  within 
the  hypothalamus.
  In chikungunya, arthralgia (pain in a joint) will be 
associated with fever and it was reported in 87% of the 
cases. Recently, many patients presented with arthralgia 
without fever. The joint pain tends to be worse in the 
morning, relieved by mild exercise and exacerbated by 
aggressive movements. Migratory polyarthritis (inflammation 
of several joints) with effusions may be seen in around 70% 
cases, but resolves in the majority. Ankles, wrists and small 
joints of the hand were the worst affected. Larger joints like 
knee and shoulder and spine were also involved. There is 
a tendency for early and more significant involvement of 
joints with some trauma or degeneration[2]. Carrageenan-
induced hind paw edema is the standard experimental 
model of acute inflammation. Carrageenan is commonly 
used for testing anti-inflammatory drugs due to absence of 
apparent systemic effects and an antigenic nature. Moreover, 
reproducibility of this model is high. Carrageenan-induced 
edema is a biphasic response. The  first  phase  is  mediated 
through the  release  of  histamine,  serotonin  and  kinins 
whereas the second  phase is  related  to prostaglandin 
release and slow reacting substances which peak at 3 h[12]. 
The EENKC treated animals showed good anti-inflammatory 
activity at 1, 3 and 5 h in carrageenan induced inflammation 
compared of control animals. This result supports the anti-
inflammatory activity of NKC in chikungunya fever. It may 
be due to inhibition of the release of first and second phase 
inflammatory mediators[13]. Moreover, backache (67 %) 
and headache (62 %) associated with chikungunya fever 
is common clinical feature[2]. Pain is a complex process 
mediated via physiological mediators such as prostaglandins, 
bradykinins, substance-P. The constrictions induced in 
mice by acetic acid results from an acute inflammatory 
reaction with production of PGE2 and prostaglandin F2 in 
the peritoneal fluid[10]. Therefore, NKC may be suppress 
the formation of above substances or prevent their action to 
produce analgesic activity. 
  At present, to manage chikungunya, no vaccine is 
available and symptomatic treatment given for mitigating 
pain and fever using anti-inflammatory drugs along 
with rest usually recommended. While recovery from 
chikungunya is the expected outcome, convalescence can 
be prolonged (up to a year or more), and persistent joint 
pain may require analgesic (pain medication) and long-
term anti-inflammatory therapy[14]. It was well documented 
that 25% of chronic NSAID users will develop ulcer disease 
and 2 to 4 % will bleed or perforate. Concerns rose due to 
potential cardiovascular risk of COX-2 inhibitors and other 
NSAIDs have complicated clinical decision to prescribe 
further[15]. Therefore, preparation which possess less or 
no toxicity, multiple therapeutic effects with cost effective 
have greater need than NSAIDs and analgesics to treat fever, 
inflammation and pain associated with chikungunya fever. 
Pharmacological actions of few medicinal plants present 
in NKC were studied extensively. Piperine, isolated from 
Piper nigrum has anti-inflammatory, antinociceptive, and 
anti-arthritic property[16,17]. Neoandrographolide, one of 
the principal diterpene lactones, isolated from a medicinal 
herb Andrographis paniculata possesses significant anti-
inflammatory effects[18]. Hepatoprotective role of the 
whole plant of Hedyotis corymbosa against paracetamol 
overdose-induced and Trichosanthes cucumerina in 
carbon tetrachloride induced liver damage in rats was well 
documented[19-21]. Rhizomes of Zingiber officinale has anti-
inflammatory, cytoprotective, anti-ulcer action in NSIADs 
induced ulcer model, hepatoprotective and antioxidant 
property in paracetamol induced animal model[22-24]. Hence, 
antipyretic, anti-inflammatory and analgesic action of NKC 
Table 3
Effect of ethanolic extract of nilavembu kudineer choornam on acetic acid induced writhing in mice.
Treatment Dose (mg/kg) Number of writhes (per 20 min)
Control Vehicle (5 mL/kg)    90.33 依 3.38
Aspirin 100     44.50 依 2.30*
EENKC 200     46.16 依 1.49*
EENKC 400     49.33 依 1.70*
All data were expressed in mean 依 SEM (n=6). *P<0.01 compared with control group.
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may be due to the presence of above phytoconstituents. 
  The present study finding, first time, supports the efficacy 
of nilavembu kudineer choornam and we conclude that 
it might be a safer, better alternative medicine in short 
and long-term treatment of chikungunya fever due to its 
multiple therapeutic actions compared to NSAIDs and 
analgesics. 
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